Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Astellas Pharma SG&A Expenses 2012-2023 | ALPMY

Astellas Pharma annual/quarterly sg&a expenses history and growth rate from 2012 to 2023. Sg&a expenses can be defined as the sum of all selling, general and administrative expenses.
  • Astellas Pharma sg&a expenses for the quarter ending December 31, 2023 were $M, a 100% decline year-over-year.
  • Astellas Pharma sg&a expenses for the twelve months ending December 31, 2023 were $3.657B, a 13.8% decline year-over-year.
  • Astellas Pharma annual sg&a expenses for 2023 were $4.739B, a 5.33% increase from 2022.
  • Astellas Pharma annual sg&a expenses for 2022 were $4.499B, a 0.97% decline from 2021.
  • Astellas Pharma annual sg&a expenses for 2021 were $4.543B, a 0.83% decline from 2020.
  
Astellas Pharma Annual SG&A Expenses
(Millions of US $)
2023 $4,739
2022 $4,499
2021 $4,543
2020 $4,581
2019 $4,417
2018 $4,513
2017 $4,203
2016 $4,153
2015 $4,118
2014 $3,855
2013 $5,613
2012 $6,332
2011 $
2010 $
2009 $
Astellas Pharma Quarterly SG&A Expenses
(Millions of US $)
2023-12-31
2023-06-30 $1,228
2022-06-30 $1,181
2021-06-30 $1,248
2020-06-30 $1,123
2019-06-30 $1,069
2018-06-30 $1,039
2017-06-30 $1,011
2016-09-30 $1,068
2016-06-30 $1,041
2016-03-31 $1,179
2015-12-31 $1,008
2015-09-30 $993
2015-06-30 $973
2015-03-31 $1,145
2014-12-31 $1,016
2014-09-30 $1,007
2014-06-30 $950
2014-03-31
2013-12-31
2013-09-30
2013-06-30 $1,522
2013-03-31
2012-12-31
2012-09-30
2012-06-30 $1,461
2012-03-31
2011-12-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $17.916B $11.108B
Astellas Pharma, Inc. is engaged in the research, development, manufacturing and marketing of pharmaceuticals drugs. Products offered by the Company include Prograf applicable for the prevention of rejection in organ transplants, Vesicare for treatment of overactive bladder, Protopic for the treatment of atopic dermatitis in the topical immunomodulator class, Harnal to treat the functional symptoms of benign prostatic hyperplasia (BPH), including weak urinary stream, frequent nighttime urination, and sensation of incomplete emptying of the bladder and Fungard an antifungal agent. Astellas Pharma, Inc. is headquartered in Tokyo, Japan.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.163B 31.78
Chugai Pharmaceutical (CHGCY) Japan $49.580B 22.16
Takeda Pharmaceutical (TAK) Japan $41.491B 8.40
Merck (MKGAF) Germany $23.587B 22.87
Sandoz Group AG (SDZNY) Switzerland $15.279B 0.00
Neurocrine Biosciences (NBIX) United States $14.138B 38.70
Shionogi (SGIOY) Japan $13.095B 11.38
United Therapeutics (UTHR) United States $11.938B 12.73
Catalent (CTLT) United States $9.773B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.470B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.623B 7.28
Revolution Medicines (RVMD) United States $6.253B 0.00
Orion OYJ (ORINY) Finland $5.645B 23.81
Ionis Pharmaceuticals (IONS) United States $5.494B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.396B 0.00
Madrigal Pharmaceuticals (MDGL) United States $4.759B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.695B 0.00
Corcept Therapeutics (CORT) United States $3.291B 29.82
Arrowhead Pharmaceuticals (ARWR) United States $2.971B 0.00
PTC Therapeutics (PTCT) United States $2.797B 0.00
Dyne Therapeutics (DYN) United States $2.622B 0.00
Indivior (INDV) United States $2.548B 12.08
Recursion Pharmaceuticals (RXRX) United States $2.137B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.096B 11.91
Catalyst Pharmaceuticals (CPRX) United States $1.957B 19.05
Fusion Pharmaceuticals (FUSN) Canada $1.825B 0.00
NewAmsterdam Pharma (NAMS) Netherlands $1.746B 0.00
Evotec AG (EVO) Germany $1.722B 0.00
Summit Therapeutics (SMMT) United States $1.678B 0.00
Ardelyx (ARDX) United States $1.606B 0.00
Taro Pharmaceutical Industries (TARO) Israel $1.605B 24.12
Avadel Pharmaceuticals (AVDL) Ireland $1.489B 0.00
Xencor (XNCR) United States $1.443B 0.00
Pacira BioSciences (PCRX) United States $1.399B 13.30
Soleno Therapeutics (SLNO) United States $1.363B 0.00
4D Molecular Therapeutics (FDMT) United States $1.287B 0.00
BioCryst Pharmaceuticals (BCRX) United States $1.277B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.131B 0.00
Collegium Pharmaceutical (COLL) United States $1.124B 6.73
Enliven Therapeutics (ELVN) United States $1.092B 0.00
Cassava Sciences (SAVA) United States $1.040B 0.00
Cronos Group (CRON) Canada $1.024B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.920B 14.34
Ocular Therapeutix (OCUL) United States $0.918B 0.00
Relay Therapeutics (RLAY) United States $0.899B 0.00
USANA Health Sciences (USNA) United States $0.894B 14.62
ARS Pharmaceuticals (SPRY) United States $0.870B 0.00
ProKidney (PROK) United States $0.851B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.814B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.755B 0.00
Sage Therapeutics (SAGE) United States $0.718B 0.00
Lyell Immunopharma (LYEL) United States $0.701B 0.00
Silence Therapeutics (SLN) United Kingdom $0.661B 0.00
Harrow (HROW) United States $0.657B 0.00
Exscientia (EXAI) United Kingdom $0.575B 0.00
Savara (SVRA) United States $0.573B 0.00
Bioventus (BVS) United States $0.549B 21.00
Siga Technologies (SIGA) United States $0.543B 6.94
Heron Therapeutics (HRTX) United States $0.514B 0.00
Altimmune (ALT) United States $0.494B 0.00
Lexeo Therapeutics (LXEO) United States $0.494B 0.00
OmniAb (OABI) United States $0.490B 0.00
Larimar Therapeutics (LRMR) United States $0.471B 0.00
KalVista Pharmaceuticals (KALV) United States $0.467B 0.00
Korro Bio (KRRO) United States $0.460B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.456B 0.00
Verve Therapeutics (VERV) United States $0.440B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.409B 0.00
Esperion Therapeutics (ESPR) United States $0.398B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.357B 0.00
Organogenesis (ORGO) United States $0.354B 66.75
Tourmaline Bio (TRML) United States $0.351B 0.00
Fractyl Health (GUTS) United States $0.315B 0.00
Nanobiotix S.A (NBTX) France $0.311B 0.00
CytoDyn (CYDY) United States $0.298B 0.00
Nature's Sunshine Products (NATR) United States $0.285B 18.14
Xeris Biopharma Holdings (XERS) United States $0.285B 0.00
Aquestive Therapeutics (AQST) United States $0.282B 0.00
ESSA Pharma (EPIX) Canada $0.278B 0.00
Nektar Therapeutics (NKTR) United States $0.275B 0.00
Century Therapeutics (IPSC) United States $0.273B 0.00
Black Diamond Therapeutics (BDTX) United States $0.264B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.253B 0.00
Foghorn Therapeutics (FHTX) United States $0.247B 0.00
Metagenomi (MGX) United States $0.241B 0.00
Acrivon Therapeutics (ACRV) United States $0.238B 0.00
Aldeyra Therapeutics (ALDX) United States $0.225B 0.00
Akebia Therapeutics (AKBA) United States $0.224B 0.00
Conduit Pharmaceuticals (CDT) United States $0.224B 0.00
Eliem Therapeutics (ELYM) United States $0.223B 0.00
Avita Medical (RCEL) United States $0.223B 0.00
Pyxis Oncology (PYXS) United States $0.220B 0.00
Prelude Therapeutics (PRLD) United States $0.204B 0.00
Elite Pharmaceuticals (ELTP) United States $0.197B 18.46
Adherex Technologies (FENC) United States $0.192B 234.33
Zevra Therapeutics (ZVRA) United States $0.191B 0.00
Telomir Pharmaceuticals (TELO) United States $0.184B 0.00
Achieve Life Sciences (ACHV) Canada $0.184B 0.00
Incannex Healthcare (IXHL) Australia $0.182B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
Innate Pharma SA (IPHYF) France $0.176B 0.00
Galectin Therapeutics (GALT) United States $0.175B 0.00
MediWound (MDWD) Israel $0.169B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.163B 0.00
Cardiol Therapeutics (CRDL) Canada $0.160B 0.00
Context Therapeutics (CNTX) United States $0.153B 0.00
VAXART, INC (VXRT) United States $0.147B 0.00
Regulus Therapeutics (RGLS) United States $0.134B 0.00
OptiNose (OPTN) United States $0.132B 0.00
FibroGen (FGEN) United States $0.127B 0.00
Karyopharm Therapeutics (KPTI) United States $0.117B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.116B 7.77
Citius Pharmaceuticals (CTXR) United States $0.114B 0.00
PMV Pharmaceuticals (PMVP) United States $0.103B 0.00
ProPhase Labs (PRPH) United States $0.098B 0.00
Assertio Holdings (ASRT) United States $0.095B 4.35
Vivani Medical (VANI) United States $0.091B 0.00
SCYNEXIS (SCYX) United States $0.089B 1.26
Relmada Therapeutics (RLMD) United States $0.089B 0.00
AlloVir (ALVR) United States $0.087B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
Marinus Pharmaceuticals (MRNS) United States $0.082B 0.00
Aclaris Therapeutics (ACRS) United States $0.075B 0.00
Journey Medical (DERM) United States $0.072B 0.00
Tempest Therapeutics (TPST) United States $0.071B 0.00
Champions Oncology (CSBR) United States $0.062B 0.00
Mural Oncology (MURA) Ireland $0.061B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.058B 0.00
BioLineRx (BLRX) Israel $0.057B 0.00
Protara Therapeutics (TARA) United States $0.057B 0.00
Nutriband (NTRB) United States $0.057B 0.00
Carisma Therapeutics (CARM) United States $0.056B 0.00
Inotiv (NOTV) United States $0.055B 0.00
CASI Pharmaceuticals (CASI) China $0.049B 0.00
Gain Therapeutics (GANX) United States $0.044B 0.00
NRx Pharmaceuticals (NRXP) United States $0.041B 0.00
ElectroCore (ECOR) United States $0.041B 0.00
Natural Alternatives (NAII) United States $0.041B 0.00
Rafael Holdings (RFL) United States $0.039B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.039B 0.00
DURECT (DRRX) United States $0.038B 0.00
VYNE Therapeutics (VYNE) United States $0.038B 0.00
Lipocine (LPCN) United States $0.035B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.035B 0.00
Surrozen (SRZN) United States $0.033B 0.00
Unicycive Therapeutics (UNCY) United States $0.031B 0.00
Viracta Therapeutics (VIRX) United States $0.029B 0.00
JanOne (JAN) United States $0.028B 0.00
Oncternal Therapeutics (ONCT) United States $0.028B 0.00
BioVie (BIVI) United States $0.028B 0.00
Enlivex Therapeutics (ENLV) Israel $0.026B 0.00
Aptorum Group (APM) United Kingdom $0.025B 0.00
TherapeuticsMD (TXMD) United States $0.025B 0.00
Iterum Therapeutics (ITRM) Ireland $0.022B 0.00
PolyPid (PYPD) Israel $0.022B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.021B 0.00
Indaptus Therapeutics (INDP) United States $0.021B 0.00
MEI Pharma (MEIP) United States $0.020B 0.78
Lyra Therapeutics (LYRA) United States $0.020B 0.00
Jaguar Animal Health (JAGX) United States $0.020B 0.00
Talphera (TLPH) United States $0.018B 0.00
Alaunos Therapeutics (TCRT) United States $0.017B 0.00
GlycoMimetics (GLYC) United States $0.017B 0.00
Nuvilex (PMCB) United States $0.017B 0.00
Minerva Neurosciences (NERV) United States $0.017B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.016B 0.00
CERo Therapeutics Holdings (CERO) United States $0.016B 0.00
Traws Pharma (TRAW) United States $0.015B 0.00
Mannatech (MTEX) United States $0.014B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.014B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.014B 0.00
Redhill Biopharma (RDHL) Israel $0.014B 0.00
TransCode Therapeutics (RNAZ) United States $0.013B 0.00
Dominari Holdings (DOMH) United States $0.013B 0.00
Cosmos Health (COSM) Greece $0.013B 0.00
Plus Therapeutics (PSTV) United States $0.012B 0.00
Avalo Therapeutics (AVTX) United States $0.012B 0.00
Inhibikase Therapeutics (IKT) United States $0.011B 0.00
Mangoceuticals (MGRX) United States $0.011B 0.00
SHINECO (SISI) China $0.011B 0.00
Biomerica (BMRA) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.009B 0.00
Molecular Templates (MTEM) United States $0.008B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.007B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Ainos (AIMD) United States $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
XORTX Therapeutics (XRTX) Canada $0.005B 0.00
Heatwurx (PCSA) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.005B 0.00
Petros Pharmaceuticals (PTPI) United States $0.004B 0.00
Phio Pharmaceuticals (PHIO) United States $0.004B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.003B 0.00
Bio-Path Holdings (BPTH) United States $0.003B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.003B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.003B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.002B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
Aditxt (ADTX) United States $0.000B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.37
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 33.05